OOIR: Observatory of International Research

Papers

(The TQCC of Immunological Reviews is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease	189
Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines	177
COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts	134
Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer	134
The molecular mechanism of RIG‐I activation and signaling	124
Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment	103
The inflammatory speech of fibroblasts	96
Regulatory B cells in cancer	94
Memory B cells and plasma cells: The differentiative continuum of humoral immunity	88
Host‐directed therapy to combat mycobacterial infections*	84
Fibroblasts as confederates of the immune system	68
Novel mechanisms and clinical trial endpoints in intestinal fibrosis*	62
Innate and adaptive γδ T cells: How, when, and why	59
T peripheral helper cells in autoimmune diseases*	56
Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis	53
Regulatory B cells: TIM‐1, transplant tolerance, and rejection	50
Osteopontin/secreted phosphoprotein‐1 harnesses glial‐, immune‐, and neuronal cell ligand‐receptor interactions to sense and regulate acute and chronic neuroinflammation	49
From thymus to periphery: Molecular basis of effector γδ‐T cell differentiation	49
Immune dynamics in the CNS and its barriers during homeostasis and disease*	49
A century of BCG: Impact on tuberculosis control and beyond	45
Molecular mechanisms controlling age‐associated B cells in autoimmunity*	42
Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS‐CoV‐2 infection*	41
Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection*	41
Classical CD4 T cells as the cornerstone of antimycobacterial immunity	40
Monocytes and macrophages in pregnancy: The good, the bad, and the ugly*	37

Fantastic IgA plasma cells and where to find them	37
Neutrophils in aging and aging‐related pathologies	36
In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae	36
Fibroblasts and macrophages: Collaborators in tissue homeostasis	36
Transcriptional regulation of adaptive and innate lymphoid lineage specification	34
Fibroblast pathology in inflammatory joint disease	33
BCG‐induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next‐generation vaccines	33
The role of neutrophils in trained immunity	32
COVID‐19 and plasma cells: Is there long‐lived protection?*	32
The Factor H protein family: The switchers of the complement alternative pathway	31
Diversity in recognition and function of human γδ T cells	31
Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators	30
Protective neutralizing epitopes in SARS‐CoV‐2	30
C3‐dependent effector functions of complement	30
Differentiation and activation of fibroblastic reticular cells	30
Imaging dendritic cell functions*	30
Know your enemy or find your friend?—Induction of IgA at mucosal surfaces	30
Human neutrophils ≠ murine neutrophils: Does it matter?	29
Mechanisms of immune regulation by the placenta: Role of type I interferon and interferon‐stimulated genes signaling during pregnancy*	29
Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function	29
Regulatory B cells in respiratory health and diseases	29
The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function	28
Emerging roles for endogenous retroviruses in immune epigenetic regulation*	27
A bird’s eye view of fibroblast heterogeneity: A pan‐disease, pan‐cancer perspective	26
Next generation of immune checkpoint molecules in maternal‐fetal immunity*	26
B regulatory cells in allergy	26
Fetal inflammatory response at the fetomaternal interface: A requirement for labor at term and preterm*	26
N1 versus N2 and PMN‐MDSC: A critical appraisal of current concepts on tumor‐associated neutrophils and new directions for human oncology	25
Extracellular vesicles in atherothrombosis: From biomarkers and precision medicine to therapeutic targets	25
The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation	25
Epigenetics and CD8⁺ T cell memory*	24
Circulating tissue factor‐positive extracellular vesicles and their association with thrombosis in different diseases	24
Macrophage‐fibroblast circuits in the spleen	24
Activation pathways that drive CD4⁺ T cells to break tolerance in autoimmune diseases*	23
Neutrophil‐T cell crosstalk and the control of the host inflammatory response	23
Novel Frontiers in Regulatory B cells	23
ZAP70, too little, too much can lead to autoimmunity*	23
Engineering the IL‐4/IL‐13 axis for targeted immune modulation	23
Unique aspects of IFN‐γ/STAT1 signaling in neurons	23
The gene regulatory network controlling plasma cell function	22
The role of donor‐unrestricted T‐cells, innate lymphoid cells, and NK cells in anti‐mycobacterial immunity	22
Ferroptosis in immunostimulation and immunosuppression	21
Pyroptosis in neutrophils: Multimodal integration of inflammasome and regulated cell death signaling pathways	21
Platelet extracellular vesicles and the secretory interactome join forces in health and disease	21
Transcriptomics for child and adolescent tuberculosis*	21
Copper homeostasis and cuproptosis in cancer immunity and therapy	21
B‐cell intrinsic and extrinsic signals that regulate central tolerance of mouse and human B cells*	20
Type I interferon and cancer	20
Engineered exosomes for studies in tumor immunology	20
Epigenetic regulation of natural killer cell memory*	20

Mast cell ontogeny: From fetal development to life‐long health and disease	20
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy	20
Susceptibility and resistance in leprosy: Studies in the mouse model	20
PANoptosis: Mechanisms, biology, and role in disease	20
Neutrophils as immune effector cells in antibody therapy in cancer	20
The emerging role for metabolism in fueling neutrophilic inflammation	19
The complement alternative pathway and hemostasis	19
Epigenetic regulation of T cell adaptive immunity	19
Neutrophil interactions with T cells, platelets, endothelial cells, and of course tumor cells	19
Tissue‐resident memory T cells and lung immunopathology	19
Conversations that count: Cellular interactions that drive T cell fate	19
Reduction of host cell mitochondrial activity as Mycobacterium leprae’s strategy to evade host innate immunity	18
Stromal cells in tertiary lymphoid structures: Architects of autoimmunity	18
How RNA modifications regulate the antiviral response	18
Targetability of the neurovascular unit in inflammatory diseases of the central nervous system	18
The formation and function of the neutrophil phagosome	18
The fibroblast: An emerging key player in thymic T cell selection	18
The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target	18
G protein coupled pattern recognition receptors expressed in neutrophils: Recognition, activation/modulation, signaling and receptor regulated functions	18
Secret messengers: Extracellular RNA communication in the immune system	17
Immunity against Mycobacterium ulcerans: The subversive role of mycolactone	17
Modulation of immunity by the secreted phospholipase A₂ family	17
Perivascular stromal cells: Directors of tissue immune niches	17
Extracellular vesicles and immune response during pregnancy: A balancing act*	17
Runx proteins and transcriptional mechanisms that govern memory CD8 T cell development	16
Neutrophils in the periodontium: Interactions with pathogens and roles in tissue homeostasis and inflammation	16
Harnessing the power of artificial intelligence to advance cell therapy	16
Role of inhibitory signaling in peripheral B cell tolerance*	16
Initiation of the alternative pathway of complement and the history of “tickover”	16
Transcriptional and epigenetic regulation of memory NK cell responses	16
Real‐time imaging of inflammation and its resolution: It’s apparent because it’s transparent*	16
Effects of immune‐related adverse events (irAEs) and their treatment on antitumor immune responses	15
The special unfolded protein response in plasma cells	15
With complements: C3 inhibition in the clinic	15
Insights into phenotypic and functional CD8⁺ T_RM heterogeneity	15
Role of hormones in the pregnancy and sex‐specific outcomes to infections with respiratory viruses*	15
Sequence determinants as key regulators in gene expression of T cells	15
Regnase‐1–related endoribonucleases in health and immunological diseases	15
Genetic variability shapes the alternative pathway complement activity and predisposition to complement‐related diseases	15
Intracellular complement: Evidence, definitions, controversies, and solutions	15
Neutrophils during SARS‐CoV‐2 infection: Friend or foe?	15
Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney	15
RNA regulatory mechanisms that control antiviral innate immunity	15
MicroRNA regulation of B cell receptor signaling	14
Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID‐19	14
Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector–based COVID‐19 vaccine	14
Immunity at maternal–fetal interface: KIR/HLA (Allo)recognition*	14
On the road to eliminating long‐lived plasma cells—“are we there yet?”	14
B cell/stromal cell crosstalk in health, disease, and treatment: Follicular lymphoma as a paradigm	14
The neutrophil: A key resourceful agent in immune‐mediated vasculitis	14
Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway	14
The coming of age of neutrophil extracellular traps in thrombosis: Where are we now and where are we headed?	14
Cell‐intrinsic and ‐extrinsic roles of miRNAs in regulating T cell immunity	14
Age‐related macular degeneration: A disease of extracellular complement amplification	14